175 related articles for article (PubMed ID: 34600647)
1. Bilosomes as effective delivery systems to improve the gastrointestinal stability and bioavailability of epigallocatechin gallate (EGCG).
Wang L; Huang X; Jing H; Ma C; Wang H
Food Res Int; 2021 Nov; 149():110631. PubMed ID: 34600647
[TBL] [Abstract][Full Text] [Related]
2. Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions.
Liang R; Chen L; Yokoyama W; Williams PA; Zhong F
J Agric Food Chem; 2016 Dec; 64(48):9180-9188. PubMed ID: 27933988
[TBL] [Abstract][Full Text] [Related]
3. Enhanced uptake and transport of (+)-catechin and (-)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells.
Song Q; Li D; Zhou Y; Yang J; Yang W; Zhou G; Wen J
Int J Nanomedicine; 2014; 9():2157-65. PubMed ID: 24855353
[TBL] [Abstract][Full Text] [Related]
4. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
[TBL] [Abstract][Full Text] [Related]
5. Addressing the Superior Drug Delivery Performance of Bilosomes─A Microscopy and Fluorescence Study.
Mondal D; Mandal RP; De S
ACS Appl Bio Mater; 2022 Aug; 5(8):3896-3911. PubMed ID: 35924346
[TBL] [Abstract][Full Text] [Related]
6. Stability of glycosylated complexes loaded with Epigallocatechin 3-gallate (EGCG).
Zhang J; Cui H; Qiu J; Wang X; Zhong Y; Yao C; Yao L; Zheng Q; Xiong C
Food Chem; 2023 Jun; 410():135364. PubMed ID: 36623458
[TBL] [Abstract][Full Text] [Related]
7. Development of gelatinized-core liposomes for the oral delivery of EGCG with improved stability, release property, and cellular antioxidant activity.
Kim Y; Baek Y; Jeong E; Lee HG
Colloids Surf B Biointerfaces; 2024 Feb; 234():113723. PubMed ID: 38194838
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of (-)-epigallocatechin gallate into liposomes and into alginate or chitosan microparticles reinforced with liposomes.
Istenič K; Cerc Korošec R; Poklar Ulrih N
J Sci Food Agric; 2016 Oct; 96(13):4623-32. PubMed ID: 26921243
[TBL] [Abstract][Full Text] [Related]
9. Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems.
Krupkova O; Ferguson SJ; Wuertz-Kozak K
J Nutr Biochem; 2016 Nov; 37():1-12. PubMed ID: 27770867
[TBL] [Abstract][Full Text] [Related]
10. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage.
Minnelli C; Moretti P; Fulgenzi G; Mariani P; Laudadio E; Armeni T; Galeazzi R; Mobbili G
Int J Pharm; 2018 Dec; 552(1-2):225-234. PubMed ID: 30291957
[TBL] [Abstract][Full Text] [Related]
11. Whey Protein Sodium-Caseinate as a Deliverable Vector for EGCG: In Vitro Optimization of Its Bioaccessibility, Bioavailability, and Bioactivity Mode of Actions.
Korin A; Gouda MM; Youssef M; Elsharkawy E; Albahi A; Zhan F; Sobhy R; Li B
Molecules; 2024 May; 29(11):. PubMed ID: 38893466
[TBL] [Abstract][Full Text] [Related]
12. Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration.
Jain S; Harde H; Indulkar A; Agrawal AK
Nanomedicine; 2014 Feb; 10(2):431-40. PubMed ID: 24036099
[TBL] [Abstract][Full Text] [Related]
13. Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity.
Mondal D; Bagchi A; Biswas S; Dagar T; Biswas A; Bagchi A; De S
ACS Appl Bio Mater; 2024 Jan; 7(1):369-378. PubMed ID: 38150107
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies.
Mehmood S; Maqsood M; Mahtab N; Khan MI; Sahar A; Zaib S; Gul S
J Food Biochem; 2022 Aug; 46(8):e14189. PubMed ID: 35474461
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant activity, storage stability and in vitro release of epigallocatechin-3-gallate (EGCG) encapsulated in hordein nanoparticles.
Song H; Wang Q; He A; Li S; Guan X; Hu Y; Feng S
Food Chem; 2022 Sep; 388():132903. PubMed ID: 35436635
[TBL] [Abstract][Full Text] [Related]
16. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles.
Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F
Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758
[TBL] [Abstract][Full Text] [Related]
17. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
Lambert JD; Kim DH; Zheng R; Yang CS
J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of self-assembled (-)-epigallocatechin gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells.
Li Z; Gu L
J Agric Food Chem; 2014 Feb; 62(6):1301-9. PubMed ID: 24446922
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells.
de Pace RC; Liu X; Sun M; Nie S; Zhang J; Cai Q; Gao W; Pan X; Fan Z; Wang S
J Liposome Res; 2013 Sep; 23(3):187-96. PubMed ID: 23600473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
